Given the evidence discussed implicating LRRK2 in the regulation of immune responses to pathogens, it is curious to speculate if epidemiological research would demonstrate increased rates of previous infections in LRRK2-PD patients relative to non-manifesting LRRK2 carriers. The gene discussed is LRRK2; the disease is Parkinson disease.